Radiotherapy Research Today is a free monthly online journal that collates and summarizes the latest research about Radiotherapy, including details on cancer treatment, side effects.

Volume 6 (2009), Issue 3 (March)

1. Gated irradiation with scanned particle beams.
   Int J Radiat Oncol Biol Phys, 73(4): 1270-5. [Abstract] [Full-text]
2. Analysis of salivary flow and dose-volume modeling of complication incidence in patients with head-and-neck cancer receiving intensity-modulated radiotherapy.
   Int J Radiat Oncol Biol Phys, 73(4): 1252-9. [Abstract] [Full-text]
3. Helical tomotherapy planning for left-sided breast cancer patients with positive lymph nodes: comparison to conventional multiport breast technique.
   Int J Radiat Oncol Biol Phys, 73(4): 1243-51. [Abstract] [Full-text]
4. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer.
   Int J Radiat Oncol Biol Phys, 73(4): 1235-42. [Abstract] [Full-text]
5. Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.
   Int J Radiat Oncol Biol Phys, 73(4): 1187-95. [Abstract] [Full-text]
6. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
   Int J Radiat Oncol Biol Phys, 73(4): 1023-32. [Abstract] [Full-text]
7. Vibro-acoustography imaging of permanent prostate brachytherapy seeds in an excised human prostate--preliminary results and technical feasibility.
   Ultrasonics, 49(3): 389-94. [Abstract] [Full-text]
8. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
   Int J Radiat Oncol Biol Phys, 73(4): 1069-76. [Abstract] [Full-text]
9. Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapy.
   Int J Radiat Oncol Biol Phys, 73(4): 1129-34. [Abstract] [Full-text]
10. Stereotactic body radiotherapy for localized prostate cancer: interim results of a prospective phase II clinical trial.
    Int J Radiat Oncol Biol Phys, 73(4): 1043-8. [Abstract] [Full-text]
11. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors.
    Int J Radiat Oncol Biol Phys, 73(4): 1121-8. [Abstract] [Full-text]
12. Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers.
    Int J Radiat Oncol Biol Phys, 73(4): 1096-103. [Abstract] [Full-text]
13. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Int J Radiat Oncol Biol Phys, 73(4): 1077-81. [Abstract] [Full-text]
14. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors.
    Cancer Res, 69(5): 2126-32. [Abstract] [Full-text]
15. Fludarabine, cyclophosphamide, anti-thymocyteglobulin, and low-dose total body irradiation conditioning enables 1-HLA-locus-mismatched hematopoietic stem cell transplantation for very severe aplastic anemia without affecting ovarian function.
    Am J Hematol, 84(3): 167-9. [Abstract] [Full-text]
16. Gender differences in the treatment of rectal cancer: a population based study.
    Eur J Surg Oncol, 35(4): 427-33. [Abstract] [Full-text]
17. Radiation to supraclavicular and internal mammary lymph nodes in breast cancer increases the risk of stroke.
    Br J Cancer, 100(5): 811-6. [Abstract] [Full-text]
18. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
    Ophthalmology, 116(3): 544-551.e1. [Abstract] [Full-text]
19. Intraoperative radiation therapy in the treatment of early-stage breast cancer utilizing xoft axxent electronic brachytherapy.
    World J Surg Oncol, 7: 24. [Abstract] [Full-text]
20. Endocavitary contact radiation therapy for ultrasonographically staged T1 N0 and T2 N0 rectal cancer.
    Br J Surg, 96(4): 430-6. [Abstract] [Full-text]
21. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy.
    J Urol, 181(4): 1658-63; discussion 1663-4. [Abstract] [Full-text]
22. Long-term outcomes in younger men following permanent prostate brachytherapy.
    J Urol, 181(4): 1665-71; discussion 1671. [Abstract] [Full-text]
23. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    J Surg Oncol, 99(5): 302-6. [Abstract] [Full-text]
24. Percutaneous implantation of fiducial markers for imaging-guided radiation therapy.
    AJR Am J Roentgenol, 192(4): 1090-6. [Abstract] [Full-text]
25. Influence of rotations on dose distributions in spinal stereotactic body radiotherapy (SBRT).
    Int J Radiat Oncol Biol Phys, 73(5): 1596-601. [Abstract] [Full-text]
26. A rabbit irradiation platform for outcome assessment of lung stereotactic radiosurgery.
    Int J Radiat Oncol Biol Phys, 73(5): 1588-95. [Abstract] [Full-text]
27. 3D in vivo dosimetry using megavoltage cone-beam CT and EPID dosimetry.
    Int J Radiat Oncol Biol Phys, 73(5): 1580-7. [Abstract] [Full-text]
28. A study on target positioning error and its impact on dose variation in image-guided stereotactic body radiotherapy for the spine.
    Int J Radiat Oncol Biol Phys, 73(5): 1574-9. [Abstract] [Full-text]
29. Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients.
    Int J Radiat Oncol Biol Phys, 73(5): 1304-12. [Abstract] [Full-text]
30. Potential dosimetric benefits of four-dimensional radiation treatment planning.
    Int J Radiat Oncol Biol Phys, 73(5): 1560-5. [Abstract] [Full-text]
31. Postoperative strontium-90 brachytherapy in the prevention of keloids: results and prognostic factors.
    Int J Radiat Oncol Biol Phys, 73(5): 1510-6. [Abstract] [Full-text]
32. Intrafraction geometric uncertainties in frameless image-guided radiosurgery.
    Int J Radiat Oncol Biol Phys, 73(5): 1364-8. [Abstract] [Full-text]
33. Early clinical experience and outcome of helical tomotherapy for multiple metastatic lesions.
    Int J Radiat Oncol Biol Phys, 73(5): 1517-24. [Abstract] [Full-text]
34. Designing targets for elective nodal irradiation in lung cancer radiotherapy: a planning study.
    Int J Radiat Oncol Biol Phys, 73(5): 1397-403. [Abstract] [Full-text]
35. Evaluation of dosimetric parameters and disease response after 125 iodine transperineal brachytherapy for low- and intermediate-risk prostate cancer.
    Int J Radiat Oncol Biol Phys, 73(5): 1432-8. [Abstract] [Full-text]
36. Stereotactic body radiotherapy for lesions of the spine and paraspinal regions.
    Int J Radiat Oncol Biol Phys, 73(5): 1369-75. [Abstract] [Full-text]
37. Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy.
    Int J Radiat Oncol Biol Phys, 73(5): 1414-24. [Abstract] [Full-text]
38. Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.
    Int J Radiat Oncol Biol Phys, 73(5): 1454-60. [Abstract] [Full-text]
39. Implanted cardiac defibrillator care in radiation oncology patient population.
    Int J Radiat Oncol Biol Phys, 73(5): 1525-31. [Abstract] [Full-text]
40. Tolerance and acceptance results of a palladium-103 permanent breast seed implant Phase I/II study.
    Int J Radiat Oncol Biol Phys, 73(5): 1482-8. [Abstract] [Full-text]
41. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Int J Radiat Oncol Biol Phys, 73(5): 1468-74. [Abstract] [Full-text]
42. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.
    Int J Radiat Oncol Biol Phys, 73(5): 1376-82. [Abstract] [Full-text]
43. Management of tracheobronchial ulceration induced by high-dose brachytherapy.
    Ann Thorac Surg, 87(4): 1301-3. [Abstract] [Full-text]
44. Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.
    J Clin Oncol, 27(10): 1653-9. [Abstract] [Full-text]
45. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    J Clin Oncol, 27(10): 1572-8. [Abstract] [Full-text]
46. Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.
    J Clin Oncol, 27(10): 1579-84. [Abstract] [Full-text]
47. Phase I study of individualized stereotactic body radiotherapy of liver metastases.
    J Clin Oncol, 27(10): 1585-91. [Abstract] [Full-text]

© 2004-2012 Radiotherapy Research Today. All Rights Reserved.